Financhill
Buy
59

VNET Quote, Financials, Valuation and Earnings

Last price:
$10.94
Seasonality move :
0.67%
Day range:
$11.31 - $11.91
52-week range:
$1.42 - $16.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.68x
P/B ratio:
3.49x
Volume:
11.1M
Avg. volume:
13.3M
1-year change:
532.22%
Market cap:
$3B
Revenue:
$1.2B
EPS (TTM):
-$0.03

VNET Analysts' Consensus Rating

The 8 analysts providing 12-month price projections for VNET Group shares anticipate an average target of $14.10, ranging from a low estimate of $4.01 to a high estimate of $23.02. This average target implies a growth of 23.94% compared to the current stock price of $11.38.

Consensus Price Target

$14.10

Highest Price Target

$23.02

Lowest Price Target

$4.01

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 3 7 7

Hold 2 0 0

Sell 0 1 1
Consensus Buy Buy Buy

VNET Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock